You would be aware that AHZ has been selling Cardiocel into Europe and have just spent a bit on a new manufacturing facility. As Russ often reminds us, their technology business brought in 8 million last year. Cardiocel will add to this - we don't have any sales numbers yet but an ANN in regards to the shipment.
Where do you think the missing revenue is Sam?
If you're pessimistic about biotechs, you shouldn't be in the game. Sleep sounder, find ya 2% interest in a bam. If you're only here for the breakout, then... seriously? Why do you think a stock which is overpriced would break anywhere but backwards?
I'm not convinced that there is a huge degree of "potential" built into the share price yet.
how far can we go? , page-2
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |